|
|
|
|
LEADER |
04441nam a2200925Ia 4500 |
001 |
10.1002-hbm.25406 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 10659471 (ISSN)
|
245 |
1 |
0 |
|a Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI
|
260 |
|
0 |
|b John Wiley and Sons Inc
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1002/hbm.25406
|
520 |
3 |
|
|a Previous pathologic studies evaluated the substantia nigra pars compacta (SNpc) of a limited number of idiopathic Parkinson's disease (IPD) patients with relatively longer disease durations. Therefore, it remains unknown which region of the SNpc is most significantly affected in early-stage IPD. We hypothesized that a voxelwise analysis of thin-section neuromelanin-sensitive MRI (NM-MRI) may help determine the significantly affected regions of the SNpc in early-stage IPD and localize these areas in each nigrosome on high-spatial-resolution susceptibility map-weighted imaging (SMwI). Ninety-six healthy subjects and 50 early-stage IPD patients underwent both a 0.8 × 0.8 × 0.8 mm3 NM-MRI and a 0.5 × 0.5 × 1.0 mm3 multi-echo gradient-recalled echo imaging for SMwI. Both NM-MRI and SMwI templates were created by using image data from the 96 healthy subjects. Permutation-based nonparametric tests were conducted to investigate spatial differences between the two groups in NM-MRI, and the results were displayed on both NM-MRI and SMwI templates. The posterolateral and anteromedial regions of the SNpc in NM-MRI were significantly different between the two groups, corresponding to the nigrosome 1 and nigrosome 2 regions, respectively, on the SMwI template. There were the areas of significant spatial difference in the hypointense SN on SMwI between early-stage IPD patients and healthy subjects. These areas on SMwI were slightly greater than those on NM-MRI, including the areas showing group difference on NM-MRI. Our voxelwise analysis of NM-MRI suggests that two regions (nigrosome 1 and nigrosome 2) of the SNpc are separately affected in early-stage IPD. © 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a affine transform
|
650 |
0 |
4 |
|a aged
|
650 |
0 |
4 |
|a Aged
|
650 |
0 |
4 |
|a anterior commissure
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a brain stem
|
650 |
0 |
4 |
|a cerebral peduncle
|
650 |
0 |
4 |
|a clinical article
|
650 |
0 |
4 |
|a Clinical Dementia Rating
|
650 |
0 |
4 |
|a cohort analysis
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a diagnostic imaging
|
650 |
0 |
4 |
|a disease duration
|
650 |
0 |
4 |
|a dopaminergic nerve cell
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Female
|
650 |
0 |
4 |
|a hand movement
|
650 |
0 |
4 |
|a Hoehn and Yahr scale
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a least square analysis
|
650 |
0 |
4 |
|a left handedness
|
650 |
0 |
4 |
|a longitudinal study
|
650 |
0 |
4 |
|a magnetic resonance imaging
|
650 |
0 |
4 |
|a Magnetic Resonance Imaging
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a Male
|
650 |
0 |
4 |
|a measurement accuracy
|
650 |
0 |
4 |
|a melanin
|
650 |
0 |
4 |
|a Melanins
|
650 |
0 |
4 |
|a mesencephalon
|
650 |
0 |
4 |
|a metabolism
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a Middle Aged
|
650 |
0 |
4 |
|a n (3 fluoropropyl) 2beta carboxymethoxy 3beta(4 iodophenyl)nortropane f 18
|
650 |
0 |
4 |
|a neuromelanin
|
650 |
0 |
4 |
|a neuromelanin
|
650 |
0 |
4 |
|a neuromelanin
|
650 |
0 |
4 |
|a neuroradiologist
|
650 |
0 |
4 |
|a nigrosome
|
650 |
0 |
4 |
|a nigrosome 1
|
650 |
0 |
4 |
|a nigrosome 2
|
650 |
0 |
4 |
|a nonparametric test
|
650 |
0 |
4 |
|a nuclear magnetic resonance imaging
|
650 |
0 |
4 |
|a Parkinson disease
|
650 |
0 |
4 |
|a Parkinson disease
|
650 |
0 |
4 |
|a Parkinson disease
|
650 |
0 |
4 |
|a Parkinson Disease
|
650 |
0 |
4 |
|a Pars Compacta
|
650 |
0 |
4 |
|a posterior commissure
|
650 |
0 |
4 |
|a priority journal
|
650 |
0 |
4 |
|a red nucleus
|
650 |
0 |
4 |
|a Retrospective Studies
|
650 |
0 |
4 |
|a retrospective study
|
650 |
0 |
4 |
|a right handedness
|
650 |
0 |
4 |
|a rigidity
|
650 |
0 |
4 |
|a substantia nigra pars compacta
|
650 |
0 |
4 |
|a substantia nigra pars compacta
|
650 |
0 |
4 |
|a substantia nigra pars compacta
|
650 |
0 |
4 |
|a susceptibility weighted imaging
|
650 |
0 |
4 |
|a tracer
|
650 |
0 |
4 |
|a unclassified drug
|
650 |
0 |
4 |
|a Unified Parkinson Disease Rating Scale
|
700 |
1 |
|
|a Kim, E.Y.
|e author
|
700 |
1 |
|
|a Noh, Y.
|e author
|
700 |
1 |
|
|a Sung, Y.H.
|e author
|
773 |
|
|
|t Human Brain Mapping
|